Filings

6 documents · 19 matches

1. VRDN Viridian Therapeutics, Inc.\DE 10-Q 2026-11-04

   Item 1A. Risk Factors

   material weakness in our internal control over financial reporting, we may not detect errors on a timely basis and our financial
   3 matches in this document Show context Copy citation

2. VRDN Viridian Therapeutics, Inc.\DE 10-Q 2026-08-06

   Item 1A. Risk Factors

   basis and our financial statements may be materially misstated. If we identify material weaknesses in our internal control over financial
   3 matches in this document Show context Copy citation

3. VRDN Viridian Therapeutics, Inc.\DE 10-Q 2026-05-05

   Item 1A. Risk Factors

   material weakness in our internal control over financial reporting, we may not detect errors on a timely basis and our financial
   3 matches in this document Show context Copy citation

4. VRDN Viridian Therapeutics, Inc.\DE 10-K 2026-02-26

   Item 1A. Risk Factors

   material weakness in our internal control over financial reporting, we may not detect errors on a timely basis and our financial
   4 matches in this document Show context Copy citation

5. VRDN Viridian Therapeutics, Inc.\DE 10-Q 2025-11-05

   Item 1A. Risk Factors

   material weakness in our internal control over financial reporting, we may not detect errors on a timely basis and our financial
   3 matches in this document Show context Copy citation

6. VRDN Viridian Therapeutics, Inc.\DE 10-Q 2025-08-06

   Item 1A. Risk Factors

   material weakness in our internal control over financial reporting, we may not detect errors on a timely basis and our financial
   3 matches in this document Show context Copy citation